ETPrime

Medi-Caps - MediCaps Share Price

  • 39.10-0.89 (-2.22%)
  • Volume: 878
BSE
  • Closed
  • Last Updated On: 08 Sep, 2025, 03:42 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Medi-Caps - MediCaps Share Price
  • 39.10-0.89 (-2.22%)
  • Volume: 878
Advertisment

Medi-Caps share price insights

View All

  • Company has no debt since last 5 years. (Source: Consolidated Financials)

  • Company witnessed QoQ revenue decline of 66.79%, which is lowest in the last 3 years. (Source: Consolidated Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 29.77% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • MediCaps Ltd. share price moved down by -2.22% from its previous close of Rs 39.99. MediCaps Ltd. stock last traded price is 39.10

    Share PriceValue
    Today/Current/Last-39.10
    Previous Day-39.99

InsightsMedi-Caps

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		-13.91
    EPS - TTM
    (₹)    		-2.81
    MCap
    (₹ Cr.)    		48.76
    Sectoral MCap Rank
    		146
    PB Ratio
    (x)    		0.41
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-0.29
    3 Months-0.44
    6 Months-0.05
    1 Year-0.01
    3 Years0.61

    		-0.29
    VWAP
    (₹)    		39.37
    52W H/L
    (₹)
    61.00 / 37.10

    Medi-Caps Ltd Share Price Returns

    1 Day-2.22%
    1 Week-1.81%
    1 Month-4.63%
    3 Months-8.64%
    1 Year-22.6%
    3 Years-17.94%
    5 Years97.47%

    ET Stock ScreenersTop Score Companies

    Check whether Medi-Caps Ltd belongs to analysts' top-rated companies list?

    View Stock Screeners

    Medi-Caps News & Analysis

    View all Medi-Caps Share News & Announcements

    Medi-Caps Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Medi-Caps Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Medi-Caps Financials

    • Insights

      • Quarterly Topline Performance

        Company witnessed QoQ revenue decline of 66.79%, which is lowest in the last 3 years. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 29.77% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income3.029.104.188.586.34
      Total Income Growth (%)-66.79117.64-51.2735.36-21.84
      Total Expenses6.507.636.238.276.90
      Total Expenses Growth (%)-14.7822.51-24.7019.91-20.73
      EBIT-3.481.47-2.050.31-0.56
      EBIT Growth (%)-336.16--754.82--
      Profit after Tax (PAT)-3.491.72-2.050.31-0.56
      PAT Growth (%)-303.21--754.82--
      EBIT Margin (%)-115.1016.18-48.903.64-8.78
      Net Profit Margin (%)-115.5318.88-48.903.64-8.78
      Basic EPS (₹)-2.801.38-1.640.25-0.45
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income0.311.160.351.070.40
      Total Income Growth (%)-72.99231.40-67.34169.70-81.13
      Total Expenses0.710.720.610.630.73
      Total Expenses Growth (%)-1.8117.76-1.87-14.09-24.44
      EBIT-0.400.44-0.260.45-0.33
      EBIT Growth (%)-191.17--159.43--129.07
      Profit after Tax (PAT)-0.400.71-0.260.45-0.33
      PAT Growth (%)-156.30--159.43--150.87
      EBIT Margin (%)-126.8837.59-75.6341.56-83.47
      Net Profit Margin (%)-126.8860.88-75.6341.56-83.47
      Basic EPS (₹)-0.320.57-0.210.36-0.27
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue28.2127.8250.9771.7959.30
      Total Revenue Growth (%)1.39-45.42-28.9921.0529.14
      Total Expenses29.0529.0746.0561.7348.06
      Total Expenses Growth (%)-0.06-36.89-25.3928.43-7.15
      Profit after Tax (PAT)-0.57-2.241.7610.0811.13
      PAT Growth (%)--227.62-82.58-9.42-
      Operating Profit Margin (%)-3.20-4.559.9714.3919.57
      Net Profit Margin (%)-2.24-8.193.5514.4219.38
      Basic EPS (₹)-0.46-1.801.418.0811.03
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue2.987.310.750.61-
      Total Revenue Growth (%)-59.26880.2422.82--
      Total Expenses2.692.490.490.67-
      Total Expenses Growth (%)8.40407.00-26.64--
      Profit after Tax (PAT)0.563.890.15-0.04-0.11
      PAT Growth (%)-85.722,554.06---
      Operating Profit Margin (%)11.7967.36252.260.000.00
      Net Profit Margin (%)22.9754.26144.470.000.00
      Basic EPS (₹)0.453.120.12-0.03-0.09

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Zero Debt Burden

        Company has no debt since last 5 years. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets125.42127.28125.99130.35114.82
      Total Assets Growth (%)-1.461.03-3.3513.5320.59
      Total Liabilities4.156.307.4214.0910.11
      Total Liabilities Growth (%)-34.20-15.02-47.3939.46137.45
      Total Equity121.28120.98118.57116.26104.71
      Total Equity Growth (%)0.242.031.9911.0215.13
      Current Ratio (x)17.2511.4111.655.055.68
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities0.00--2.002.00
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets68.0368.0961.6361.8162.64
      Total Assets Growth (%)-0.0910.48-0.29-1.331.77
      Total Liabilities0.681.600.520.521.67
      Total Liabilities Growth (%)-57.50207.690.00-68.86-2.34
      Total Equity67.3466.4961.1161.2960.97
      Total Equity Growth (%)1.288.80-0.290.521.87
      Current Ratio (x)81.6618.63194.68197.8113.78
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities0.00--2.002.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 4.98 cr for investing activities which is an YoY decrease of 35.6%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities5.076.94-6.087.0215.32
      Net Cash used in Investing Activities-4.98-7.73-2.56-4.08-9.70
      Net Cash flow from Financing Activities0.00----0.06
      Net Cash Flow0.09-0.79-8.642.955.56
      Closing Cash & Cash Equivalent0.410.321.119.756.81
      Closing Cash & Cash Equivalent Growth (%)28.19-71.14-88.5843.26443.49
      Total Debt/ CFO (x)0.000.000.000.000.00
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities1.853.09-2.60-0.952.24
      Net Cash used in Investing Activities-1.85-3.091.851.01-2.19
      Net Cash flow from Financing Activities0.00----0.06
      Net Cash Flow0.010.01-0.750.06-0.02
      Closing Cash & Cash Equivalent0.050.050.040.790.73
      Closing Cash & Cash Equivalent Growth (%)15.4212.10-94.858.09-2.32
      Total Debt/ CFO (x)0.000.000.000.000.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)-0.47-1.851.488.6710.62
      Return on Capital Employed (%)-0.66-1.024.078.5810.64
      Return on Assets (%)-0.45-1.761.397.739.69
      Interest Coverage Ratio (x)36.370.004,166.000.000.00
      Asset Turnover Ratio (x)0.200.220.00--
      Price to Earnings (x)-90.91-24.6924.886.154.52
      Price to Book (x)0.430.460.370.530.48
      EV/EBITDA (x)56.94124.766.374.393.41
      EBITDA Margin (%)3.541.6113.5016.9922.22
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)0.825.840.23-0.06-0.18
      Return on Capital Employed (%)0.427.210.41-0.090.00
      Return on Assets (%)0.815.710.23-0.06-0.17
      Interest Coverage Ratio (x)0.000.000.000.000.00
      Asset Turnover Ratio (x)0.040.110.00--
      Price to Earnings (x)93.4614.22303.03-1,666.67-476.19
      Price to Book (x)0.770.830.711.010.83
      EV/EBITDA (x)116.1811.07125.011,940.530.00
      EBITDA Margin (%)18.4169.60343.290.000.00

    Financial InsightsMedi-Caps

    • Income (P&L)
    • Balance Sheet
    • Cash Flow

      • Quarterly Topline Performance

        Company witnessed QoQ revenue decline of 66.79%, which is lowest in the last 3 years. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 29.77% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Zero Debt Burden

        Company has no debt since last 5 years. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 4.98 cr for investing activities which is an YoY decrease of 35.6%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Medi-Caps Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Medi-Caps Ltd Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Medi-Caps Ltd-13.910.40-0.47-0.66-0.45-26.53-3.20-2.24-0.4617.250.000.00
          Biofil Chem25.683.832.964.041.0914.212.311.660.341.340.03-0.25
          Concord Drugs154.641.930.986.970.51-8.416.000.740.341.560.504.62
          Godavari Drugs16.871.4710.1014.793.06-10.759.133.865.821.081.425.50
          Vista Pharma-11.911.33-10.23-9.02-7.71163.16-42.93-46.14-0.791.190.16-1.06
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Transchem Ltd
          • Sandu Pharma
          • Kabra Drugs
          • Roopa Ind
          • Veerhealth Care

          Choose from Stocks

            See All Parameters

          Peers InsightsMedi-Caps

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Medi-Caps Shareholding Pattern

            • Loading...
              Showing Medi-Caps Shareholding as on Jun 2025
              CategoryJun 2025Mar 2025Dec 2024Sep 2024
              Promoters50.7750.7750.6250.43
              Pledge0.000.000.000.00
              FII0.000.000.000.00
              DII0.010.010.010.01
              Mutual Funds0.010.010.010.01
              Others49.2249.2249.3749.56
            • Showing Shareholding as on Jun 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters63,30,55250.77 %0.00
              Pledge00.00 %0.00
              DII9000.01 %0.00
              MF9000.01 %0.00
              Others61,38,50449.22 %0.00

            Medi-Caps MF Ownership

            MF Ownership details are not available.

            Top Searches:
            Medi-Caps Ltd News Medi-Caps Ltd Quarterly Results Medi-Caps Ltd Dividend Medi-Caps Ltd Q1 ResultsMedi-Caps Ltd Q2 ResultsMedi-Caps Ltd Q3 ResultsMedi-Caps Ltd Q4 Results

            Medi-Caps Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Sep 18, 2025Aug 26, 2025AGM-
              Aug 05, 2025Jul 28, 2025Board MeetingQuarterly Results
              May 21, 2025May 14, 2025Board MeetingAudited Results
              Feb 12, 2025Feb 03, 2025Board MeetingQuarterly Results
              Nov 12, 2024Nov 06, 2024Board MeetingQuarterly Results
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final15%1.5Sep 20, 2012Aug 13, 2012
              Final 15%1.5Sep 22, 2011Sep 02, 2011
              Final 15%1.5Sep 22, 2010Aug 27, 2010
              Final 15%1.5Sep 24, 2009Aug 05, 2009
              Final 15%1.5Sep 24, 2008Aug 01, 2008
            • All TypesEx-DateRecord DateAnnounced onDetails
              BonusMar 19, 2013Mar 20, 2013Feb 07, 2013Bonus Ratio: 3 share(s) for every 1 shares held
              RightsFeb 03, 1995Mar 07, 1995Jan 20, 1995Rights ratio: 1 share for every 5 held at a price of Rs 126.0
              RightsJul 24, 1992Aug 28, 1992Sep 29, 1992Rights ratio: 1 share for every 2 held at a price of Rs 10.0
              Rights-Dec 10, 1991Sep 30, 1991Rights ratio: 2 share for every 5 held at a price of Rs 10.0

            About Medi-Caps

            MediCaps Ltd., incorporated in the year 1983, is a Small Cap company (having a market cap of Rs 49.88 Crore) operating in Pharmaceuticals sector. MediCaps Ltd. key Products/Revenue Segments include Office/Shops/Flats, Other Operating Revenue, Lease Rentals and Interest for the year ending 31-Mar-2024. Show More

            • Executives

            • Auditors

            • RC

              Ramesh Chandra Mittal

              Chairman & Non-Exe.Director
              AK

              Alok K Garg

              Managing Director
              KM

              Kusum Mittal

              Non Executive Woman Director
              AO

              Ashok Omprakash Agrawal

              Ind. Non-Executive Director
              Show More
            • Rawka & Associates

            Industry

            Pharma - Indian

            Key Indices Listed on

            -

            Address

            Mhow Neemuch Road,Sector - I, Pithampur,Dhar, Madhya Pradesh - 454775

            Contact

            investors@medicaps.com

            http://www.medicaps.com

            More Details

            Trending in Markets

            Top Gainers As on 03:59 PM | 08 Sep 2025

            Suven Pharma 1,012.95
            90.06 (9.76%)
            Guj Mineral Dev.539.15
            30.15 (5.93%)
            Bharat Forge1,202.80
            66.10 (5.82%)
            Ashok Leyland137.29
            6.52 (4.99%)
            JP Power20.02
            0.95 (4.99%)

            Top Losers As on 03:57 PM | 08 Sep 2025

            Amber Enterprises7,473.00
            -320.50 (-4.12%)
            EID Parry1,067.30
            -45.50 (-4.09%)
            Trent5,315.50
            -213.00 (-3.86%)
            Godfrey Philips10,657.00
            -416.00 (-3.76%)
            Coromandel Int.2,185.20
            -72.71 (-3.22%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Medi-Caps Ltd Share Price
            The Economic Times
            BrowseCompanies: